Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 25,697 | 20,674 | 23,118 | 16,716 | 22,584 |
| Operating Income | -25,697 | -20,674 | -23,118 | -16,716 | -22,584 |
| Other Income | 3,823 | 3,257 | 1,925 | 2,315 | 1,017 |
| Pre-tax Income | -21,874 | -17,417 | -21,193 | -14,401 | -21,567 |
| Net Income Continuous | -21,874 | -17,417 | -21,193 | -14,401 | -21,567 |
| Net Income | $-21,874 | $-17,417 | $-21,193 | $-14,401 | $-21,567 |
| EPS Basic Total Ops | -0.65 | -0.70 | -6.62 | -5.52 | -10.79 |
| EPS Basic Continuous Ops | -0.65 | -0.70 | -6.63 | -5.52 | -10.78 |
| EPS Diluted Total Ops | -0.65 | -0.70 | -6.62 | -5.52 | -10.79 |
| EPS Diluted Continuous Ops | -0.65 | -0.70 | -6.63 | -5.52 | -10.78 |
| EPS Diluted Before Non-Recurring Items | -0.65 | -0.70 | N/A | N/A | N/A |
| EBITDA(a) | $-25,697 | $-20,674 | $-23,118 | $-16,716 | $-22,584 |